A comprehensive view of Implantable Drug Delivery / Smart Pills. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Study finds Sanofi’s Beyfortus nirsevimab significantly reduced RSV lower respiratory tract disease and hospitalizations in infants in the 2023-2024 RSV season; the drug showed an 82% reduction in infant hospitalizations from RSV
Published:
May 02, 2024
by Sanofi SA
|
Celanese announces collaboration with Secarna Pharmaceuticals for development of long-acting implants that deliver therapies; Celanese contributes its VitalDose Drug Delivery Platform
Published:
March 20, 2024
by Celanese Corp.
|
Ashland introduces Viatel Ultrapure high-purity bioresorbable polymers for stable and extended drug release in injectables and implants
Published:
October 16, 2023
by Ashland Inc.
|
GlobalData: Nanotechnology in healthcare is revolutionizing medicine through precise drug delivery, early disease detection and advanced imaging techniques, promising improved treatments and patient outcomes; highlights include smart pills, smart bandages
Published:
October 10, 2023
by ForeignAffairs.co.nz
|
Ask us about our R&D/Patents market view